Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Alx Oncology Holdings Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 76 | +2 |
| Shares | 34.3M | 66.2K | 33.3M | −945.7K (−2.8%) |
| Value | $257.5M | $497.2K | $159.8M | −$97.3M (−37.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HSBC Holdings PLC | 35,404 | $168.2K | 0.00% |
| First Republic Investment Management, Inc. | 20,000 | $96.0K | 0.00% |
| Zacks Investment Management | 13,918 | $66.8K | 0.00% |
| Forefront Analytics, LLC | 13,769 | $66.1K | 0.04% |
| Verition Fund Management LLC | 11,649 | $55.9K | 0.00% |
| Prelude Capital Management, LLC | 10,900 | $52.3K | 0.00% |
| XTX Topco Ltd | 10,740 | $51.6K | 0.01% |
| American Century Companies Inc | 10,257 | $49.2K | 0.00% |
| SG Americas Securities, LLC | 10,069 | $48.0K | 0.00% |
| Comerica Bank | 688 | $3.30K | 0.00% |
| Parallel Advisors, LLC | 329 | $1.58K | 0.00% |
| Advisor Group Holdings, Inc. | 182 | $873 | 0.00% |
Sold out (10)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Artal Group S.A. | 500,000 | $3.75M |
| Millennium Management LLC | 123,933 | $930.7K |
| HRT Financial LP | 25,176 | $189.0K |
| Gsa Capital Partners LLP | 12,730 | $96.0K |
| MetLife Investment Management | 11,556 | $86.8K |
| Y-Intercept (Hong Kong) Ltd | 10,615 | $79.7K |
| UBS Asset Management Americas Inc | 11,581 | $52.3K |
| Asset Dedication, LLC | 1,463 | $11.0K |
| Metropolitan Life Insurance Co | 1,201 | $9.02K |
| Russell Investments Group, Ltd. | 269 | $2.02K |
Not filed for Q3 2023 yet (1)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 66,211 | $497.2K |